SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors
Background Calprotectin is a major S100 leucocyte protein, associated with disease activity in rheumatoid arthritis (RA) patients. Calprotectin is a potentially biomarker more sensitive of disease activity than conventional acute-phase reactans.
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2015
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/26451
- Acceso en línea:
- https://doi.org/10.1136/annrheumdis-2015-eular.3394
https://repository.urosario.edu.co/handle/10336/26451
- Palabra clave:
- Calprotectin
leucocyte protein
rheumatoid arthritis
patients
- Rights
- License
- http://purl.org/coar/access_right/c_14cb
| id |
EDOCUR2_d8f78b426c51c498bf403533d89b92d8 |
|---|---|
| oai_identifier_str |
oai:repository.urosario.edu.co:10336/26451 |
| network_acronym_str |
EDOCUR2 |
| network_name_str |
Repositorio EdocUR - U. Rosario |
| repository_id_str |
|
| spelling |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitorsSAT0118 La calprotectina estratifica la actividad de la enfermedad mejor que los reactivos de fase aguda en pacientes con artritis reumatoide que reciben inhibidores del TNFCalprotectinleucocyte proteinrheumatoid arthritispatientsBackground Calprotectin is a major S100 leucocyte protein, associated with disease activity in rheumatoid arthritis (RA) patients. Calprotectin is a potentially biomarker more sensitive of disease activity than conventional acute-phase reactans.BMJ Publishing Group2015-062020-08-06T16:24:05Zinfo:eu-repo/semantics/conferenceObjecthttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_c94fapplication/pdfhttps://doi.org/10.1136/annrheumdis-2015-eular.3394ISSN: 0959-8138EISSN: 1756-1833https://repository.urosario.edu.co/handle/10336/26451Annals of the Rheumatic Diseasesinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURenghttps://ard.bmj.com/content/74/Suppl_2/693.1http://purl.org/coar/access_right/c_14cbInciarte-Mundo, J.Hernández, M.Ruiz-Esquide, V.Ramírez, J.Cuervo, A.Amaya, J.Pascal, M.Yagüe, J.Cañete, J.Sanmarti, R.oai:repository.urosario.edu.co:10336/264512021-06-03T00:51:05Z |
| dc.title.none.fl_str_mv |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors SAT0118 La calprotectina estratifica la actividad de la enfermedad mejor que los reactivos de fase aguda en pacientes con artritis reumatoide que reciben inhibidores del TNF |
| title |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors |
| spellingShingle |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors Calprotectin leucocyte protein rheumatoid arthritis patients |
| title_short |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors |
| title_full |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors |
| title_fullStr |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors |
| title_full_unstemmed |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors |
| title_sort |
SAT0118 Calprotectin stratifies disease activity better than acute phase reactants in rheumatoid arthritis patients receiving TNF inhibitors |
| dc.subject.none.fl_str_mv |
Calprotectin leucocyte protein rheumatoid arthritis patients |
| topic |
Calprotectin leucocyte protein rheumatoid arthritis patients |
| description |
Background Calprotectin is a major S100 leucocyte protein, associated with disease activity in rheumatoid arthritis (RA) patients. Calprotectin is a potentially biomarker more sensitive of disease activity than conventional acute-phase reactans. |
| publishDate |
2015 |
| dc.date.none.fl_str_mv |
2015-06 2020-08-06T16:24:05Z |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/conferenceObject |
| dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_c94f |
| dc.identifier.none.fl_str_mv |
https://doi.org/10.1136/annrheumdis-2015-eular.3394 ISSN: 0959-8138 EISSN: 1756-1833 https://repository.urosario.edu.co/handle/10336/26451 |
| url |
https://doi.org/10.1136/annrheumdis-2015-eular.3394 https://repository.urosario.edu.co/handle/10336/26451 |
| identifier_str_mv |
ISSN: 0959-8138 EISSN: 1756-1833 |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
https://ard.bmj.com/content/74/Suppl_2/693.1 |
| dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_14cb |
| rights_invalid_str_mv |
http://purl.org/coar/access_right/c_14cb |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
BMJ Publishing Group |
| publisher.none.fl_str_mv |
BMJ Publishing Group |
| dc.source.none.fl_str_mv |
Annals of the Rheumatic Diseases instname:Universidad del Rosario reponame:Repositorio Institucional EdocUR |
| instname_str |
Universidad del Rosario |
| institution |
Universidad del Rosario |
| reponame_str |
Repositorio Institucional EdocUR |
| collection |
Repositorio Institucional EdocUR |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1803710439964540928 |